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Introduction
Sex is always a risk because of the danger of altering genomes
that are well adapted to the existing environment. Nonetheless,
sexual reproduction has emerged as the rule in the vast majority
of species. To this end, repartition of individuals into two
morphologically distinct genders is accomplished by a
developmental process termed sex determination. During this
process a germ-cell-containing, undifferentiated gonad is
converted into either a male or a female specialized
reproductive organ. Concomitantly, all necessary additional
structures permitting copulation are formed. Here, we discuss
the molecular mechanisms acting in the sex determination
process, emphasising the role of pre-mRNA splicing
regulators.
A cornucopia of sexual strategies
A surprising variety of mechanisms is used in a number of
organisms to produce differentiation into two sexes
(Zarkower, 2001). Sex can be genetically determined or
controlled by environmental conditions. Different sex
determination mechanisms are even used within the same
species, and in some cases individuals can belong sequentially
first to one sex and then to the other. In addition, in several
species animals are hermaphrodites, bearing both a male and
a female gonad. Why has such a variety of strategies evolved
that elicit the same result, production of two types of sexually
distinct individuals? Marin and Baker have argued that this
diversity is not specific to sex determination but only easier to
detect compared with other developmental processes (Marin
and Baker, 1998). Nevertheless, we are beginning to
appreciate how related genes may play conserved roles in the
most downstream steps of the sex determination pathway in
different species.
Alternative splicing, sex and death in Drosophila
melanogaster
One of the organisms in which the sex determination pathway
has been elucidated in greatest detail is Drosophila
melanogaster (Schütt and Nöthiger, 2000). Although the
molecular mechanisms governing sex determination in this
species do not constitute a universal paradigm, they represent
a revealing example of the complexity of the sex determination
cascade. 
In D. melanogaster a ratio of X chromosomes to autosomes
equal to 1 produces females; a ratio of 0.5 produces males. X-
linked genes are dosage compensated in males by
transcriptional upregulation. The X-to-autosome ratio signal
impinges upon the expression of the sex-lethal (Sxl) gene,
which encodes an RNA-binding protein endowed with two
RNP-type RNA-binding domains that have affinity to uridine-
rich sequences. In females a high level of SXL prevents
assembly of spliceosomes on the male-specific exon 3 within
its own transcript. SXL also represses translation of MSL-2, a
component of the dosage compensation complex, by binding
to untranslated regions of its mRNA. In the absence of Sxl,
overexpression of X-linked genes in female flies is lethal. SXL
facilitates the use of a downstream alternative 3¢ splice site in
the transformer (tra) pre-mRNA, binding to a sequence next
to a stronger upstream 3 ¢ splice site and blocking access of
U2AF. Alternative splicing allows the production of a full-
length TRA protein in females but not in males. TRA, which
contains an RS domain, heterodimerizes with the product of
the transformer2 (tra2) gene, which encodes an RNA-binding
protein endowed with one RNP-type RNA-binding domain and
two RS domains. TRA/TRA2 heterodimers bind to a splicing
enhancer situated within the female-specific exon 4 of the
doublesex (dsx) gene and stimulate the use of the 3 ¢ splice site
of this exon, through formation of a complex containing SR
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A remarkable array of strategies is used to produce sexual
differentiation in different species. Complex gene
hierarchies govern sex determination pathways, as
exemplified by the classic D. melanogaster paradigm, where
an interplay of transcriptional, splicing and translational
mechanisms operate. Molecular studies support the
hypothesis that genetic sex determination pathways evolved
in reverse order, from downstream to upstream genes, in
the cascade. The recent identification of a role for the key
regulatory factors SRY and WT1(+KTS) in pre-mRNA
splicing indicates that important steps in the mammalian
sex determination process are likely to operate at the post-
transcriptional level. 
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proteins and RS-domain-mediated interactions with the U2AF
small subunit. This triggers expression of a short isoform of
the dsx gene in females (DSXF), whereas males express a
longer isoform (DSXM). Both isoforms are transcription
factors, binding sequences present in the promoters of genes
involved in sexual differentiation through an N-terminal DNA-
binding domain, the DM domain (Raymond et al., 1998).
Specificity in the effects of DSXF compared with DSXM is
obtained through the sex-specific protein C-terminus. Sexual
differentiation in the nervous system is also under the control
of the TRA-TRA2 complex, which activates a female-specific
5¢ splice site in the fruitless gene and regulates production of
sex-specific isoforms (FRUF and FRUM). Sxl is also required
for oogenesis in the germline, whereas tra2 plays a role in
spermatogenesis. 
Patterns of mammalian sex differentiation
Compared with the neatly defined D. melanogaster paradigm,
our understanding of the molecular mechanisms involved in
mammalian sex determination is still at an early stage.
However, cloning of genes responsible for human sex reversal
syndromes and studies of mouse mutants have helped to
identify at least some of the key players in the mammalian sex
determination cascade (reviewed in Swain and Lovell-Badge,
1999). 
In mammals, an undifferentiated gonad forms from the
intermediate mesoderm. During this bipotential stage, two
ductal structures are present: the Wolffian duct, which will
differentiate into the epidydimis and vas deferens in the male;
and the Müllerian duct, which is the progenitor of the oviducts,
uterus and upper vagina in the female. A few genes are known
to play a master role in gonadogenesis, namely Wilms’ tumor
(Wt1), the orphan nuclear receptor Sf1, the LIM homeobox
Lhx1 and Lhx9, the homeobox Emx2 and the Polycomb group
M33. Once the bipotential gonad is formed, the critical event
in sex determination is the formation of Sertoli cells rather than
ovarian follicle cells. Sertoli cells release the Müllerian-
inhibiting substance (MIS), which triggers the regression of
Müllerian ducts in males. In the absence of MIS production,
the default female differentiation program is activated. This
critical stage is regulated by the testis-determining factor SRY,
whose gene is present on the Y chromosome. SRY is the
founder member of the SOX family, whose members share
similarity in their HMG domains (see below). Another SOX
factor, SOX9, is also required for testis differentiation. In the
absence of SRY, ovaries are developed. Another important
determinant of testis differentiation is the FGF9 growth factor,
which appears to function downstream of SRY to stimulate
mesenchymal proliferation, cell migration and Sertoli cell
differentiation. Finally, once gonadal sex has been determined,
gonad differentiation ensues. In males, genes involved in testis
differentiation include Wt1, Sf1, Gata4, Dhh, Sox9 and Dmrt1.
Conversely, the Wnt4 signalling molecule suppresses Leydig
cell differentiation in the ovary.
Conservation of downstream effectors 
Wilkins has put forward a stimulating hypothesis for evolution
of the sex determination pathway of Caenorhabditis elegans,
and possibly other genetic sex determination cascades, in
which he suggested that the pathway evolved in reverse order
from the final steps up to the first in the cascade (Wilkins,
1995). This hypothesis predicts that evolutionary conservation
should exist among the most downstream genes in the cascade.
The cloning of the male C. elegans sexual regulatory gene
mab-3, which encodes a protein that has a domain similar to
the DNA-binding domain of DSX in the fly (for this reason
named the DM domain) has provided evidence for Wilkins’
hypothesis. Ectopically expressed DSXM can restore
differentiation of C. elegans male-specific phenotypic
characters in mab-3 mutant animals (Raymond et al., 1998).
Moreover, at least three DM-motif-containing proteins are
encoded by genes on human distal chromosome 9p, a locus
associated with XY sex reversal (Ottolenghi and McElreavey,
2000). However, male mice lacking the mab-3 homologue
Dmrt1 are not sex reversed, but have hypoplastic testes with
disorganized seminiferous tubules (Raymond et al., 2000). It is
possible that, in mammals in which the DM domain family has
diverged to yield several members, multiple genes have
acquired the function of dsx in D. melanogaster and mab-3 in
C. elegans. This issue will probably be clarified when mice
lacking multiple DM domain genes become available. 
How does SRY work?
An important step in our understanding of mammalian sex
determination was the identification of SRY (Sinclair et al.,
1990). The protein encoded by SRY contains an HMG domain,
a DNA-binding domain present in some chromatin-associated
proteins of the high mobility group family and some
transcription factors. The HMG domain is the only domain
common to Sry proteins from different species. In addition, a
large family of genes (Sox genes) that encode proteins similar
to SRY only in their HMG domain (Sry box) has been cloned.
On the basis of these similarities, SRY, and the related Sox
proteins, are considered to work by binding to specific DNA
sequences and modulating transcription of target genes
(reviewed in Wegner, 1999; Kamachi et al., 2000). In vitro
binding site selection has identified the A/TAACAAT/A
sequence as the preferred SRY-recognition site on linear DNA
(Harley et al., 1994). However, SRY is a fairly atypical
transcription factor. It has a relatively high binding affinity for
nonspecific DNA sequences, and mutations in its binding site
are often well tolerated (Ferrari et al., 1992; Harley et al.,
1992). Similarly to other HMG domain factors, SRY bends
DNA by partial intercalation in the minor groove and can also
bind to four-way junctions and to cisplatin-modified DNA
(Ferrari et al., 1992; Pontiggia et al., 1994; Trimmer et al.,
1998). In addition, mouse Sry contains a C-terminal domain
endowed with a glutamine-rich region that acts as a
transcriptional activation domain. This domain is required for
male sex determination in transgenic mice (Bowles et al., 1999)
but is absent from human SRY and even from some mouse
species. 
SRY is thought to work as an architectural factor modulating
local chromatin structure in the vicinity of target genes to
favour the assembly of the transcriptional machinery (Wegner,
1999; Kamachi et al., 2000). However, target genes for SRY
remain unknown. One idea is that SRY directly activates the
MIS gene promoter (Haqq et al., 1994), but the time lag
between SRY and MIS expression in the male gonad and the
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absence of transactivation properties in human SRY suggest
that other genes directly regulated by SRY mediate its effects.
One of these is probably SOX9. Conversely, the existence of
phenotypically male XX individuals lacking SRY has led to the
hypothesis that SRY works as a negative regulator of a gene
(Z) that in turn negatively regulates the male sex determination
pathway (McElreavey et al., 1993). According to this
hypothesis, XX males lacking SRY harbor mutations that
inactivate the Z gene. Recessive mutations causing female-to-
male sex reversal are known in a variety of species (Vaiman
and Pailhoux, 2000). In the goat, the polled intersex syndrome
(PIS) associates polledness and female-to-male sex reversal. A
chromosomal deletion responsible for PIS in goats alters the
expression of two transcripts: PISRT1, a non-coding RNA; and
FOXL2, a putative forkhead transcription factor (Pailhoux et
al., 2001). These two are potential candidates for Z, together
with WNT4, which represses Leydig cell differentiation in the
ovary (Vainio et al., 1999) and the products of genes present
on human distal chromosome 9p (Ottolenghi and McElreavey,
2000).
Recent studies showing that the HMG domains of two
different Sox proteins, Sox3 and Sox9, can substitute for the
Sry HMG domain and trigger male sex determination in
transgenic mice further complicate matters (Bergstrom et al.,
2000). Since multiple Sox genes, including Sox3, are expressed
in the developing XX and XY gonads during the period critical
for sex determination (Collignon et al., 1996), it is not clear
what makes SRY act in such a specific way to trigger the male
differentiation pathway. 
Splicing regulators in mammalian sex determination
Despite the lack of direct evidence that human SRY functions
as a transcription factor, transcriptional regulation is commonly
evoked when people speculate about its mechanism of action
(reviewed in Clarkson and Harley, 2002). Recent studies,
however, have shown that the SRY and other SOX factors play
a role in pre-mRNA splicing in mammalian cells. In fact,
nuclear extracts depleted of SOX6 have an impaired splicing
activity in vitro. Splicing activity of SOX6-depleted nuclear
extracts can be restored not only by addition of the recombinant
HMG domain of SOX6 but also by SRY and the SOX9 HMG
domain (Ohe et al., 2002). SRY and SOX6 are localized in
splicing factor compartments in the nucleus (Misteli, 2000).
Furthermore, blockage of splicing in living cells causes
redistribution of SRY and SOX6 into enlarged nuclear speckles
(Ohe et al., 2002). At this stage, the most likely mechanism for
SRY and other SOX proteins function in pre-mRNA splicing
is through interaction with RNA. Veretnik and Gribskov have
identified similarity between the SRY HMG domain and the
RNA-binding domain of the hepatitis delta small antigen
(Veretnik and Gribskov, 1999). Indeed, we have confirmed that
SRY and SOX6 can bind RNA (E.L., K.O. and P.S.-C.,
unpublished). By binding to RNA in spliceosomes, SRY and
SOX proteins might induce its bending and thereby modulate
protein-RNA and RNA-RNA interactions that allow
spliceosome rearrangements during splicing (Steitz, 1992;
Staley and Guthrie, 1998). Another possibility is that SRY and
SOX proteins regulate alternative splicing of specific pre-
mRNAs by binding to sequences adjacent to splice sites and
thereby inhibiting or stimulating their use in a manner similar
to the splicing regulators SXL and TRA in the fly (Fig. 1).
Another gene that plays a crucial role in mammalian sex
determination and encodes splicing-regulating proteins is Wt1.
The WT1 isoforms that include a lysine-threonine-serine
(KTS) sequence at the end of exon 9 localize to nuclear
speckles, interact with the U2AF65 splicing factor and
associate with spliceosomes (Larsson et al., 1995; Davies et al.,
1998). WT1 also interacts with WTAP, the mammalian
homologue of D. melanogaster female-lethal(2)d, which is
required for the female-specific splicing of the sxl and tra pre-
mRNAs (Little et al., 2000). Interestingly, WTAP has been
isolated as a component of active human splice complexes
(Zhou et al., 2002).
Dominant donor splice site mutations impairing
WT1(+KTS) expression produce Frasier syndrome, which is
characterized by progressive glomerulopathy and male-to-




















Fig. 1. Mechanisms for SRY and SOX protein function in pre-mRNA splicing. (a) Possible interaction with structures mimicking a four-way
junction that favors spliceosome rearrangements during splicing (redrawn from Steitz, 1992). (b) Activation (top) or repression (bottom) of
alternative splice site usage through binding to specific RNA sequences. 
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recently described a mouse model for Frasier syndrome
(Hammes et al., 2001). Homozygous XY Frasier mice show,
in addition to glomerulosclerosis, significantly reduced Sry
expression and complete sex reversal. Conversely, XY mice in
which the expression of WT1(–KTS) isoforms has been
selectively ablated still express male-specific genes in severely
hypoplasic gonads. These findings strongly argue for a specific
role of WT1 (+KTS) isoforms in the sex determination process. 
On the basis of these findings, we suggest that WT1 (+KTS)
isoforms and SRY regulate the expression of critical testis
differentiation genes at the post-transcriptional level, with
WT1 (+KTS) lying upstream in the cascade and also
controlling genes required for kidney development. SRY, in
turn, would repress the expression of one or more genes acting
negatively upon male sex determination. The pathways of sex
determination in D. melanogaster and mammals, showing the
positive and negative effects of gene products upon subsequent
steps in the cascade, are shown in parallel in Fig. 2. 
Conclusions
Regulation at the transcriptional level is believed to be the
essential mechanism governing the mammalian sex
determination cascade (Swain and Lovell-Badge, 1999;
Clarkson and Harley, 2002). We propose that an important new
wrinckle needs to be added to this view: regulation at the level
of splicing. Indeed, in addition to notable evolutionary
conservation of some genes involved in sex determination, it
appears that pre-mRNA splicing regulatory mechanisms
constitute a common theme among distant phyla. Further
studies are now required to identify genes that play critical
roles in the sex determination process and are subject to
regulation at the post-transcriptional level.
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